BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 15745097)

  • 1. Hereditary nonpolyposis colorectal cancer (Lynch syndrome): criteria for identification and management.
    Kouraklis G; Misiakos EP
    Dig Dis Sci; 2005 Feb; 50(2):336-44. PubMed ID: 15745097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of promoters of mismatch repair genes hMSH2 and hMLH1 in hereditary nonpolyposis colorectal cancer and early onset colorectal cancer patients: identification of three novel germ-line mutations in promoter of the hMSH2 gene.
    Shin KH; Shin JH; Kim JH; Park JG
    Cancer Res; 2002 Jan; 62(1):38-42. PubMed ID: 11782355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features and hMSH2/hMLH1 germline mutation screening of Chinese hereditary nonpolyposis colorectal cancer patients].
    Liu SR; Wang ZJ; Zhao B; Wan YL; Huang YT
    Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):714-7. PubMed ID: 15200905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status.
    Oliveira C; Westra JL; Arango D; Ollikainen M; Domingo E; Ferreira A; Velho S; Niessen R; Lagerstedt K; Alhopuro P; Laiho P; Veiga I; Teixeira MR; Ligtenberg M; Kleibeuker JH; Sijmons RH; Plukker JT; Imai K; Lage P; Hamelin R; Albuquerque C; Schwartz S; Lindblom A; Peltomaki P; Yamamoto H; Aaltonen LA; Seruca R; Hofstra RM
    Hum Mol Genet; 2004 Oct; 13(19):2303-11. PubMed ID: 15294875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and mismatch repair gene mutation screening in Chinese patients with hereditary nonpolyposis colorectal carcinoma.
    Liu SR; Zhao B; Wang ZJ; Wan YL; Huang YT
    World J Gastroenterol; 2004 Sep; 10(18):2647-51. PubMed ID: 15309712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etiology, natural history, management and molecular genetics of hereditary nonpolyposis colorectal cancer (Lynch syndromes): genetic counseling implications.
    Lynch HT; Lemon SJ; Karr B; Franklin B; Lynch JF; Watson P; Tinley S; Lerman C; Carter C
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):987-91. PubMed ID: 9419392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic testing for hereditary nonpolyposis colorectal cancer.
    Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M
    Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations.
    Wijnen J; Khan PM; Vasen H; van der Klift H; Mulder A; van Leeuwen-Cornelisse I; Bakker B; Losekoot M; Møller P; Fodde R
    Am J Hum Genet; 1997 Aug; 61(2):329-35. PubMed ID: 9311737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutations of hMLH1 and hMSH2 genes in patients with suspected hereditary nonpolyposis colorectal cancer and sporadic early-onset colorectal cancer.
    Yuan Y; Han HJ; Zheng S; Park JG
    Dis Colon Rectum; 1998 Apr; 41(4):434-40. PubMed ID: 9559627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer. Part II: Hereditary nonpolyposis colorectal carcinoma as a model.
    Lynch HT; Watson P; Shaw TG; Lynch JF; Harty AE; Franklin BA; Kapler CR; Tinley ST; Liu B; Lerman C
    Cancer; 1999 Dec; 86(11 Suppl):2457-63. PubMed ID: 10630171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of concurrent germ-line mutations in hMSH2 and/or hMLH1 in Japanese hereditary nonpolyposis colorectal cancer kindreds.
    Nakahara M; Yokozaki H; Yasui W; Dohi K; Tahara E
    Cancer Epidemiol Biomarkers Prev; 1997 Dec; 6(12):1057-64. PubMed ID: 9419403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical analysis and molecular genetic study of hereditary nonpolyposis colorectal cancer kindreds].
    Luo DC; Cai Q; Sun MH; Ni YZ; Tao CW; Chen ZJ; Shi DR
    Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(3):158-62. PubMed ID: 15062061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer.
    Curia MC; Palmirotta R; Aceto G; Messerini L; Verì MC; Crognale S; Valanzano R; Ficari F; Fracasso P; Stigliano V; Tonelli F; Casale V; Guadagni F; Battista P; Mariani-Costantini R; Cama A
    Cancer Res; 1999 Aug; 59(15):3570-5. PubMed ID: 10446963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression.
    Scartozzi M; Bianchi F; Rosati S; Galizia E; Antolini A; Loretelli C; Piga A; Bearzi I; Cellerino R; Porfiri E
    J Clin Oncol; 2002 Mar; 20(5):1203-8. PubMed ID: 11870161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic testing among high-risk individuals in families with hereditary nonpolyposis colorectal cancer.
    Ponz de Leon M; Benatti P; Di Gregorio C; Pedroni M; Losi L; Genuardi M; Viel A; Fornasarig M; Lucci-Cordisco E; Anti M; Ponti G; Borghi F; Lamberti I; Roncucci L
    Br J Cancer; 2004 Feb; 90(4):882-7. PubMed ID: 14970868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline, somatic and epigenetic events underlying mismatch repair deficiency in colorectal and HNPCC-related cancers.
    Yuen ST; Chan TL; Ho JW; Chan AS; Chung LP; Lam PW; Tse CW; Wyllie AH; Leung SY
    Oncogene; 2002 Oct; 21(49):7585-92. PubMed ID: 12386821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for defective DNA mismatch repair in stage II and III colorectal cancer patients.
    Chai SM; Zeps N; Shearwood AM; Grieu F; Charles A; Harvey J; Goldblatt J; Joseph D; Iacopetta B
    Clin Gastroenterol Hepatol; 2004 Nov; 2(11):1017-25. PubMed ID: 15551255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.
    Umar A; Boland CR; Terdiman JP; Syngal S; de la Chapelle A; Rüschoff J; Fishel R; Lindor NM; Burgart LJ; Hamelin R; Hamilton SR; Hiatt RA; Jass J; Lindblom A; Lynch HT; Peltomaki P; Ramsey SD; Rodriguez-Bigas MA; Vasen HF; Hawk ET; Barrett JC; Freedman AN; Srivastava S
    J Natl Cancer Inst; 2004 Feb; 96(4):261-8. PubMed ID: 14970275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diagnostics of cancer predisposition: hereditary non-polyposis colorectal carcinoma and mismatch repair defects.
    Bocker T; Rüschoff J; Fishel R
    Biochim Biophys Acta; 1999 May; 1423(3):O1-O10. PubMed ID: 10382540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.